Loading clinical trials...

Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT00784589

Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus

Pemphigus is a severe and sometimes life-threatening disease with a mortality rate between 5 and 10 percent depending on the severity of disease and age of patients. The standard of care is high dose...

Lead sponsor: University Hospital, Rouen•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Not Yet RecruitingPhase 1/2

A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.

NCT06663943 · Pemphigus Disease, Pemphigus Vulgaris (PV)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 14, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment90

Start dateJul 2009

Last updatedJun 14, 2017

Condition

Pemphigus Disease

Locations shown

CHU de Rouen - Hôpitaux de Rouen

Rouen, Seine Maritime

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 14, 2017Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions